Muenster University Hospital,
Muenster, Germany
To the Editor:
Jaski et al,1 in their article in
Circulation, provide important information regarding
exercise physiology during long-term TCI Heartmate left
ventricular assist device (LVAD) support. They indicate
that the native left ventricle contributes directly to systemic cardiac
output during exercise yet do not attempt to quantify left
ventricular contribution.
In our institution, of more than 660 patients referred for cardiac
transplantation between 1990 and 1997, 50 patients had to receive LVAD
support, 39 by the Novacor,2 7 by the TCI
Heartmate, and 4 by the Medos system. We have reported a protocol for
the Novacor LVAD that allows for quantitation of native left
ventricular function.3 A similar
protocol was developed for the TCI Heartmate LVAD with the purpose of
(a) quantifying left ventricular contribution and (b)
assessing left ventricular functional reserve. A 7.5F
thermodilution Swan-Ganz catheter was placed in the pulmonary
artery. Cardiac output, pulmonary capillary wedge pressure,
pulmonary artery pressure, and right atrial pressure as well as
arterial pressure (by cuff inflation) were recorded at
rest, during upright bicycle exercise after 5 minutes on the 25-, 50-,
and 75-W levels as well as 3 and 10 minutes after exercise.
Simultaneously, TCI Heartmate LVAD
hemodynamic data (pump rate, pump stroke volume, pump
output) were automatically recorded. Data were compared by
subtraction. Two different LVAD settings were chosen. In setting 1
("fill-to-empty"), we achieved maximal pump washout in conjunction
with optimal pump output, as did Jaski et al.1 In
this setting, the aortic valve remained largely closed as assessed by
simultaneous transthoracic
echocardiography. The LVAD acted as a series pump.
The left ventricle was unloaded. Setting 2 ("fixed rate mode")
consisted of a fixed pump rate of 50/min so that synchronization of
pump and native left ventricular action was no longer
possible. In this situation, incomplete emptying of the left ventricle
into the pump was encountered with a resultant rise in left
ventricular load. Thus the pump rate reduction actually led
to an afterload and preload challenge for the native left ventricle. In
this situation, total cardiac output even at rest was substantially
supported by the recipient's own heart as documented by aortic valve
opening. The LVAD acted as a parallel pump.
This protocol was, as a pilot test with institutional review board
approval and patient informed consent, applied in the last 3 of our 7
TCI Heartmate recipients (all men; mean age, 50±12 years; 1
idiopathic, 2 ischemic cardiomyopathy)
after recovery (117±20 days after surgery) and informed consent. At
the time of the study, all patients were receiving vasodilators,
aspirin, and dipyridamole. Results are summarized in
the Table
It has been shown that exercise testing in LVAD recipients can be
safely performed.4 Patients with the TCI left
ventricular assist device walked up to 6 miles and were in
New York Heart Association class II.5 Functional
benefit with increase of peak O2 to 15 mL/kg per
minute and normalization of neurohormones has been
reported.6 In the Pittsburgh series, in 31
Novacor patients, mean peak O2 increased from 10
to 15 mL/kg per minute.7 All of these LVAD
exercise protocols have assessed the combined function of the left
heartleft ventricular assist device complex without
quantifying the specific contribution of the native left ventricle.
With the proposed protocol, the relative contribution of the native
left ventricle to total stroke volume and cardiac output may be
quantified. Furthermore, left ventricular functional
reserve can be safely and reliably assessed in clinically stable TCI
Heartmate patients. Thus this protocol may facilitate prediction of
left ventricular recovery and the potential for weaning,
the potential for chronic LVAD support, as well as estimation of the
risk associated with device dysfunction.
References
1.
Jaski BE, Kim J, Maly RS, Branch KR, Adamson R, Favrot LK,
Smith SC, Dembitsky WP. Effects of exercise during long-term support
with a left ventricular assist device.
Circulation.. 1997;95:24012406.
2.
Scheld HH, Hammel D, Schmid C, Weyand M, Deng M, Möllhoff
TH, Kerber S. Beating heart implantation of a wearable Novacor
left-ventricular assist device. Thorac Cardiovasc
Surg.. 1996;44:6266.[Medline]
[Order article via Infotrieve]
3.
Deng MC, Wilhelm M, Weyand M, Hammel D, Kerber S, Breithardt G,
Scheld HH. Long term left ventricular assist device support: a novel
pump rate challenge exercise protocol to monitor native left
ventricular function. J Heart Lung
Transplant.. 1997;16:629635.[Medline]
[Order article via Infotrieve]
4.
Branch KR, Dembitsky WP, Peterson KL, Adamson R, Gordon
JB, Smith SC Jr, Jaski BE. Physiology of the native heart and Thermo
Cardiosystems left ventricular assist device complex at
rest and during exercise: implications for chronic support.
J Heart Lung Transplant.. 1994;13:641651.[Medline]
[Order article via Infotrieve]
5.
McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki
H, Hobbs RE, Pashkow FJ, and the Implantable LVAD Study Group.
Implantable left ventricular assist device: approaching an
alternative for end-stage heart failure. Circulation.
1994;90(suppl 2):II-83II-86.
6.
Levin HR, Chen JM, Oz MC, Catanese KA, Krum H, Goldsmith RL,
Packer M, Rose EA. Potential of left ventricular assist
devices as outpatient therapy while awaiting transplantation. Ann
Thorac Surg.. 1994;58:15151520.[Abstract]
7.
Kormos RL, Murali S, Dew MA, Armitage JM, Hardesty RL, Borovetz
HS, Griffith BP. Chronic mechanical circulatory support:
rehabilitation, low morbidity, and superior survival. Ann Thorac
Surg.. 1994;57:5158.[Abstract]
San Diego Cardiac Center,
San Diego, Calif
We appreciate Dr Deng and his coworkers for acknowledging the
findings of the EVADE pilot trial and for providing additional data in
their carefully studied three patients. We also found that from rest to
peak exercise, Fick systemic blood flow increased significantly more
than left ventricular assist device (LVAD) output (2.8±1.9
versus 1.6±1.1, P<.05), implying parallel ejection of
blood through the native aortic valve in the fill-to-empty mode used
for our study. The fixed-rate protocol used by Dr Deng and coworkers
for quantifying LV contribution may serve as a valuable tool either for
predicting LV recovery before LVAD explant or for evaluating patient
safety during chronic LVAD support. Both of our studies address the
need for additional data from larger prospective studies to help
understand the unique physiology of the LV-LVAD complex as well as to
further define the role of the LVAD in long-term implantation.
We disagree with the calculation of percent LVSV through an LVSV/RVSV
ratio, because it implies that LVAD filling occurs only during LV
systole. Because LVAD filling also occurs during LV
diastole in response to the negative pressure induced by
the LVAD during its filling phase,1 the actual percent
LVSV ejected through the native aortic valve during LV systole should
be, in fact, higher than the values reported in their study.
References
1.
Branch KR, Dembitsky WP, Peterson KL, Adamson R,
Gordon JB, Smith SC Jr, Jaski BE. Physiology of the native heart
and Thermo Cardiosystems left ventricular assist device
complex at rest and during exercise: implications for chronic
support. J Heart Lung Transplant.. 1994;13:641651.
© 1998 American Heart Association, Inc.
Correspondence
Effects of Exercise During Long-term Support With a Left Ventricular Assist Device
. The main finding was the quantification of
the percentage left ventricular stroke volume across the
aortic valve (between zero and 53% of total=right
ventricular stroke volume) and a higher percent left
ventricular stroke volume (53±14% versus 15±12%;
P=.024) on the 75-W level in setting 2 compared with setting
1. The difference may be considered as left ventricular
functional reserve.
View this table:
[in a new window]
Table 1. TCI Heartmate Settings 1 and 2 and Associated Changes Before,
During, and After Exercise in 3 Patients
Response
This article has been cited by other articles:
![]() |
S. Klotz, M. C. Deng, J. Stypmann, J. Roetker, M. J. Wilhelm, D. Hammel, H. H. Scheld, and C. Schmid Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support Ann. Thorac. Surg., January 1, 2004; 77(1): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmid, D. Hammel, M. C. Deng, M. Weyand, H. Baba, T. D. T. Tjan, G. Drees, N. Roeder, C. Schmidt, and H. H. Scheld Ambulatory Care of Patients With Left Ventricular Assist Devices Circulation, November 9, 1999; 100 (2009): II-224 - II-228. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |